These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2539716

  • 21. Phase II study of infusional cisplatin in combination with etoposide in the treatment of small cell lung cancer.
    Mori K, Ohta S, Kishiro I, Yokoyama K, Suga Y, Tominaga K.
    Eur J Cancer; 1995 Oct; 31A(11):1781-4. PubMed ID: 8541100
    [Abstract] [Full Text] [Related]

  • 22. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
    Collins C, Higano CS, Livingston RB, Griffin BR, Keppen MD, Miller TP.
    Cancer Chemother Pharmacol; 1989 Oct; 24(2):128-32. PubMed ID: 2543513
    [Abstract] [Full Text] [Related]

  • 23. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM.
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
    Johnson BE, Bridges JD, Sobczeck M, Gray J, Linnoila RI, Gazdar AF, Hankins L, Steinberg SM, Edison M, Frame JN, Pass H, Nesbitt J, Holden D, Mulshine JL, Glatstein E, Ihde DC.
    J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
    [Abstract] [Full Text] [Related]

  • 29. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
    Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS.
    Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
    [Abstract] [Full Text] [Related]

  • 30. Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial.
    Boni C, Cocconi G, Bisagni G, Ceci G, Peracchia G.
    Cancer; 1989 Feb 15; 63(4):638-42. PubMed ID: 2536584
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
    Schiller JH, Ettinger DS, Larson MM, Gradishar W, Merkel D, Johnson DH.
    Eur J Cancer; 1994 Feb 15; 30A(2):158-61. PubMed ID: 8155389
    [Abstract] [Full Text] [Related]

  • 35. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct 15; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 36. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.
    McCracken JD, Janaki LM, Crowley JJ, Taylor SA, Giri PG, Weiss GB, Gordon W, Baker LH, Mansouri A, Kuebler JP.
    J Clin Oncol; 1990 May 15; 8(5):892-8. PubMed ID: 2159055
    [Abstract] [Full Text] [Related]

  • 37. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [Abstract] [Full Text] [Related]

  • 38. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
    Ihde DC, Mulshine JL, Kramer BS, Steinberg SM, Linnoila RI, Gazdar AF, Edison M, Phelps RM, Lesar M, Phares JC.
    J Clin Oncol; 1994 Oct 15; 12(10):2022-34. PubMed ID: 7931470
    [Abstract] [Full Text] [Related]

  • 39. Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma.
    Bonomi P, Rowland K, Taylor SG, Reddy S, Lee MS, Faber LP, Warren W.
    Semin Oncol; 1986 Sep 15; 13(3 Suppl 3):115-20. PubMed ID: 3764446
    [Abstract] [Full Text] [Related]

  • 40. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S.
    J Clin Oncol; 1987 Dec 15; 5(12):1880-9. PubMed ID: 2824710
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.